The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 778K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

12 articles for P Artursson


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
59
Identification of Triazolothiadiazoles as Potent Inhibitors of the dCTP Pyrophosphatase 1.EBI
Karolinska Institutet
35
Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1.EBI
Karolinska Institutet
8
Exploration and pharmacokinetic profiling of phenylalanine based carbamates as novel substance p 1-7 analogues.EBI
Uppsala University
30
Vinylated linear P2 pyrimidinyloxyphenylglycine based inhibitors of the HCV NS3/4A protease and corresponding macrocycles.EBI
TBA
17
Constrained H-Phe-Phe-NH2 analogues with high affinity to the substance P 1-7 binding site and with improved metabolic stability and cell permeability.EBI
Uppsala University
12
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.EBI
Uppsala University
44
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.EBI
Uppsala University
1
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).EBI
Uppsala University
3
Structure-activity relationships for lipoprotein lipase agonists that lower plasma triglycerides in vivo.EBI
Ume£
5
Achiral pyrazinone-based inhibitors of the hepatitis C virus NS3 protease and drug-resistant variants with elongated substituents directed toward the S2 pocket.EBI
Uppsala University
2
Novel Peptidomimetic Hepatitis C Virus NS3/4A Protease Inhibitors Spanning the P2-P1' Region.EBI
Uppsala University
28
Piperazin-1-ylpyridazine Derivatives Are a Novel Class of Human dCTP Pyrophosphatase 1 Inhibitors.EBI
Karolinska Institutet